Deal-Making Insights for the Life Sciences Industry
March 9–10, 2021 Virtual Event
BROUGHT TO YOU BY
Cross-functional perspectives on successfully identifying and executing strategic partnerships, licensing and M&A deals
With so many factors affecting the potential value of a transaction, it is essential for life science organizations to effectively assess the risks associated with a deal, explore innovative models and deal structures for working with strategic partners, collaborate with cross-functional partners to realize business synergies, and develop processes for the efficient and optimal negotiation and closing of a transaction.
The BD&L Summit for Life Sciences will provide attendees with valuable insights and actionable strategies from cross-functional business development teams on successfully managing alliances, licensing agreements, and M&A deals. This event serves as an educational platform for industry experts responsible for R&D, search and evaluation, external innovation, legal/IP, portfolio management, alliance management, business development and licensing, and will feature leadership representation from biotechs, mid-sized and large pharmaceutical, medical device and diagnostics companies.